Therapeutic fashion and publication bias: the case of anti-arrhythmic drugs in heart attack.
作者信息
Hampton John
机构信息
Department of Cardiology, Queen's Medical Centre, University of Nottingham, Nottingham NG7 2UH, UK
出版信息
J R Soc Med. 2015 Oct;108(10):418-20. doi: 10.1177/0141076815608562.
Abstract
摘要
相似文献
1
Therapeutic fashion and publication bias: the case of anti-arrhythmic drugs in heart attack.
J R Soc Med. 2015 Oct;108(10):418-20. doi: 10.1177/0141076815608562.
2
The effect of lorcainide on arrhythmias and survival in patients with acute myocardial infarction: an example of publication bias.
Int J Cardiol. 1993 Jul 1;40(2):161-6. doi: 10.1016/0167-5273(93)90279-p.
3
Comparison of the efficacy of newly developed antiarrhythmic drugs in the treatment of ventricular tachyarrhythmias.
Eur Heart J. 1984 Sep;5 Suppl B:87-94. doi: 10.1093/eurheartj/5.suppl_b.87.
4
The prophylactic use of anti-arrhythmic drugs in acute myocardial infarction.
Singapore Med J. 1973 Sep;14(3):205-10.
5
Evaluation of lorcainide, a new anti-arrhythmic agent.
S Afr Med J. 1981 Dec 12;60(24):929-31.
6
The true lorcainide story.
BMJ. 2015 Jan 28;350:h287. doi: 10.1136/bmj.h287.
7
Antiarrhythmic drug therapy (Part 2). Benefits and hazards.
Chest. 1985 Oct;88(4):618-24. doi: 10.1378/chest.88.4.618.
8
[Lorcainide in the prevention of ventricular arrhythmias in myocardial infarct].
Minerva Cardioangiol. 1983 Nov;31(11):663-70.
9
[Mishaps with anti-arrhythmic agents used to reduce mortality after infarction].
Rev Prat. 1992 Nov 1;42(17):2175-8.
10
Lorcainide in the prophylaxis of ventricular arrhythmias in acute myocardial infarction.
Ann Clin Res. 1984;16(1):18-22.
引用本文的文献
1
Developing the collaboration between the James Lind Library and the .
J R Soc Med. 2020 Jul;113(7):266-269. doi: 10.1177/0141076820937539.
2
The trials and tribulations of the University Group Diabetes Program 2: lessons and reflections.
J R Soc Med. 2019 Dec;112(12):503-511. doi: 10.1177/0141076819890263.
3
Climate change and conflict: more than a fashionable association with health.
J R Soc Med. 2015 Oct;108(10):381. doi: 10.1177/0141076815610024.
本文引用的文献
1
Evidence-based medicine, opinion-based medicine, and real-world medicine.
Perspect Biol Med. 2002 Fall;45(4):549-68. doi: 10.1353/pbm.2002.0070.
2
The effect of lorcainide on arrhythmias and survival in patients with acute myocardial infarction: an example of publication bias.
Int J Cardiol. 1993 Jul 1;40(2):161-6. doi: 10.1016/0167-5273(93)90279-p.
3
Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction.
N Engl J Med. 1981 Apr 2;304(14):801-7. doi: 10.1056/NEJM198104023041401.
4
Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction.
Br Med J. 1980 Mar 29;280(6218):885-8. doi: 10.1136/bmj.280.6218.885.
5
Antifibrillatory efficacy of encainide, loracainide and ORG 6001 compared with lignocaine in isolated hearts of rabbits and guinea-pigs.
Br J Pharmacol. 1981 Jun;73(2):373-7. doi: 10.1111/j.1476-5381.1981.tb10431.x.
6
The end of clinical freedom.
Br Med J (Clin Res Ed). 1983 Oct 29;287(6401):1237-8. doi: 10.1136/bmj.287.6401.1237.
7
Should every survivor of a heart attack be given a beta-blocker? Part I. Evidence from clinical trials.
Br Med J (Clin Res Ed). 1982 Jul 3;285(6334):33-6. doi: 10.1136/bmj.285.6334.33.
8
Effect of propranolol in myocardial infarction.
Lancet. 1965 Sep 18;2(7412):551-3. doi: 10.1016/s0140-6736(65)90863-9.
9
10
Meta-analytic evidence against prophylactic use of lidocaine in acute myocardial infarction.
Arch Intern Med. 1989 Dec;149(12):2694-8.
Zotero 插件